From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. Berberine may affect CYP enzymes and P-glycoprotein, creating theoretical exposure changes for roflumilast.
Mechanism. Potential CYP and transporter modulation.
Recommendation. Avoid adding high-dose berberine without clinician review if roflumilast adverse effects or severe COPD instability are present.
Stack Score
How it moves the number.
Effect on the composite score
If both Berberine and Roflumilast are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1Calverley PM et al. Roflumilast in symptomatic chronic obstructive pulmonary disease. Lancet. 2009.Needs sourceNo link